Island Pharmaceuticals Ltd (ila) Logo

Island Pharmaceuticals Ltd (ILA)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

ILA ASX Chart

Snapshot

Island Pharmaceuticals Limited (ILA) is focused on areas of unmet need for drugs that can address urgent viral diseases, public health or biosecurity threats. The Company is executing a dual development strategy for its assets, ISLA-101 and Galidesivir.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +225.09%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 915 of 2,335
Sector Rank 60 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies AVH / NYR / IMUDA
EPS -$0.031
DPS $0.00
Book Value Per Share $0.024

Broker Consensus

ILA is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Hawthorn East VIC 3123
Website www.islandpharmaceuticals.com
Registry Automic Group
Auditor William Buck Audit (VIC) Pty Ltd
Date Listed 13 Apr 2021

Upcoming Calendar (Forecasted)

Date Event
28/08/2026 Report (Prelim)
28/08/2026 Report (Annual)
24/02/2027 Report (Interim)

Former Company Names

  • Island Pharmaceuticals Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

ILA directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
03/12/25 Jason Carroll Exercise 974,930 $0.07 $68,245 Exercise of options
03/12/25 Jason Carroll Buy +974,930 $0.07 $68,245 Exercise of options
03/12/25 Christopher Ntoumenopoulos Exercise 844,568 $0.07 $59,119 Exercise of options
03/12/25 Christopher Ntoumenopoulos Buy +844,568 $0.07 $59,119 Exercise of options
02/12/25 Jason Carroll Transfer 366,666 $0.545 $199,832 As advised by the company
12/11/25 Jason Carroll Issued 5,000,000 $0.00 $500 Issue of options
12/11/25 David Foster Issued 2,000,000 $0.00 $200 Issue of options
12/11/25 Christopher Ntoumenopoulos Issued 2,750,000 $0.00 $275 Issue of options
30/10/25 Christopher Ntoumenopoulos Issued 346,666 $0.15 $51,999 Issue of securities
30/10/25 David Foster Issued 160,000 $0.15 $24,000 Issue of securities
24/07/25 Jason Carroll Buy +124,250 $0.17 $21,122 On-market trade
19/03/25 Phillip(Phil) Lynch Buy +80,000 $0.06 $4,800 Exercise of options
19/03/25 Phillip(Phil) Lynch Exercise 80,000 $0.06 $4,800 Exercise of options
05/03/25 David Foster Buy +500,000 $0.06 $30,000 Exercise of options
05/03/25 David Foster Exercise 500,000 $0.06 $30,000 Exercise of options
12/02/25 David Foster Buy +20,588 $0.06 $1,235 Exercise of options
12/02/25 David Foster Exercise 20,588 $0.06 $1,235 Exercise of options
10/02/25 Phillip(Phil) Lynch Issued 3,000,000 $0.00 $300 Issue of options
10/12/24 Christopher Ntoumenopoulos Issued 2,000,000 $0.001 $2,000 Issue of options
10/12/24 David Foster Issued 4,000,000 $0.15 $600,000 Issue of options
04/12/24 Christopher Ntoumenopoulos Issued 1,689,136 $0.07 $118,239 Issue of securities
04/12/24 Christopher Ntoumenopoulos Issued 1,689,136 $0.17 $287,153 Issue of options
19/06/24 David Foster Buy +20,588 $0.06 $1,235 Exercise of options
19/06/24 David Foster Issued 20,588 $0.08 $1,647 Issue of options
19/06/24 David Foster Exercise 20,588 $0.06 $1,235 Exercise of options
30/04/24 Paul MacLeman Expiry 2,325,000 $0.053 $123,225 Options expired
30/04/24 David Foster Expiry 533,334 $0.053 $28,266 Options expired
30/04/24 David Brookes Expiry 400,000 $0.053 $21,200 Options expired
30/04/24 Anna Lavelle Expiry 400,000 $0.053 $21,200 Options expired
30/04/24 Albert Hansen Expiry 400,000 $0.053 $21,200 Options expired
26/03/24 Paul MacLeman Issued 33,572 $0.06 $2,014 Rights issue
26/03/24 Paul MacLeman Issued 33,572 $0.06 $2,014 Rights issue
26/03/24 David Foster Issued 20,588 $0.06 $1,235 Rights issue
26/03/24 David Foster Issued 500,000 $0.06 $30,000 Rights issue
26/03/24 David Foster Issued 520,588 $0.06 $31,235 Rights issue
26/03/24 David Brookes Issued 40,000 $0.06 $2,400 Rights issue
26/03/24 David Brookes Issued 40,000 $0.06 $2,400 Rights issue
26/03/24 Anna Lavelle Issued 40,000 $0.06 $2,400 Rights issue
26/03/24 Anna Lavelle Issued 40,000 $0.06 $2,400 Rights issue
26/03/24 Albert Hansen Issued 166,667 $0.06 $10,000 Rights issue
26/03/24 Albert Hansen Issued 166,667 $0.06 $10,000 Rights issue
04/04/23 Albert Hansen Expiry 23,030 $0.07 $1,612 Options expired
03/08/22 David Foster Transfer 40,000 $0.185 $7,400 Off-market transfer
03/08/22 David Foster Transfer 40,000 $0.185 $7,400 Off-market transfer
03/08/22 David Foster Buy +31,303 $0.202 $6,327 On-market trade
21/06/22 David Foster Buy +40,000 $0.13 $5,200 On-market trade
18/11/21 David Brookes Issued 100,000 $0.25 $25,000 Director remuneration
18/11/21 Albert Hansen Issued 100,000 $0.25 $25,000 Director remuneration
18/11/21 Anna Lavelle Issued 100,000 $0.25 $25,000 Director remuneration
Show All

Director Interests

The current holdings of ILA directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Jason Carroll 03/12/2025 32,074,930 N/A 6,341,597 N/A
Christopher Ntoumenopoulos 03/12/2025 0 2,880,370 5,594,568 N/A
David Foster 12/11/2025 6,306,829 197,631 6,000,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 1, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Dr William James Garner 41,690,073 16.86%
Bnp Paribas Nominees Pty Ltd Ib Au Noms Retailclient 32,786,461 13.26%
Mr Jason Alan Carroll 31,100,000 12.58%
Dr Daniel Tillett 14,010,000 5.67%
Dr David C Foster 6,146,829 2.49%
Mr Neville James Miles 5,708,237 2.31%
Buprestid Pty Ltd Hanlon Family S/F A/C 2,853,285 1.15%
Citicorp Nominees Pty Limited 2,812,395 1.14%
S3 Consortium Pty Ltd 2,500,000 1.01%
Mr Anthony Stephen Cormack 2,140,000 0.87%
JAF Capital Pty Ltd 1,850,000 0.75%
P R Perry Nominees Pty Ltd Donesk Family A/C 1,810,000 0.73%
Mr Alistair Robert Baker 1,626,101 0.66%
Lillucy Pty Ltd Lilypily Super Fund A/C 1,500,000 0.61%
Mrs Patricia Fernandes Dias De Almeida 1,453,146 0.59%
Icader Nominees Pty Ltd Icader Investments A/C 1,433,333 0.58%
Mrs Helen Frances Baker 1,403,720 0.57%
Grayhawk Capital Pty Ltd 1,333,333 0.54%
Mr Yusuf Faruque Ismail & Mrs Ingrid Helen Ismail 1,300,000 0.50%
HSBC Custody Nominees (Australia) Limited Gsco Customers A/C 1,273,508 0.52%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 53 340 219 548 208 1,368

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
MWP Partners Limited 01/08/2025 19,264,773 8.25
Jason Alan Carroll 03/12/2025 32,074,930 11.92
William James Garner 03/12/2025 41,690,073 15.50
Daniel Tillett 03/12/2025 20,973,789 7.80

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
03-12-25 Daniel Tillett 6,963,789 5.55 7.80
03-12-25 Jason Alan Carroll 1,099,180 13.26 11.92
16-07-25 William James Garner 8,491,907 14.21 16.86

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
14-08-25 Daniel Tillett 117,577 6.72 5.55

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.14 30 June
2024 $0.077 28 June
2023 $0.095 30 June
2022 $0.145 30 June
2021 $0.28 30 June
ILA Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.